Generic drugs and mailorder systems can save health plans money since brand name drugs generally cost 50 percent to 70 percent more than generics.
The Kansas City Star reports on one of the nations largest pharmacy distribution and marketing operations “Prescription Solutions, a UnitedHealth Group company, sells to [...]

Mpex Pharmaceuticals, Inc. announced positive data from its Phase 2b clinical trial with Aeroquin((R)) (a novel aerosol formulation of levofloxacin, MP376) in cystic fibrosis (CF). Trial results showed that nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa (P. aeruginosa) in sputum after 28 days of dosing versus placebo. Clinically and [...]

Protalix BioTherapeutics, Inc. (NYSEAmexPLX), announced that it has received notice from the U.S. Food and Drug Administration (FDA) that the FDAs Office of Orphan Products Development has granted orphan drug designation to prGCD, the Companys proprietary plant cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. Gaucher disease is a lysosomal [...]

Cytopia Limiteds (ASX CYT) Investigational New Drug Application (IND) for CYT387 has passed US Food and Drug Administration (FDA) review. CYT387 is a smallmolecule oral JAK1/JAK2 kinase inhibitor designed to treat various haematological disorders. The companys IND application is now active and Cytopia is able to proceed with clinical trials for CYT387 in the United [...]

LakewoodAmedex Inc., (LA), the antiinfectives biopharmaceutical company developing a unique portfolio of antibacterial and antiviral products including NuBiotics, a novel family of synthetic antibacterial compounds, and antiviral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum antiinfluenza product into clinical studies.
LakewoodAmedexs nRNA product works by selectively silencing [...]

A new analysis of 20 years of data contradicts previously published claims that United States pharmaceutical companies are better innovators than their European counterparts, and questions whether Americans actually benefit from the higher prices they pay for many prescription medications. The reanalysis by Donald W. Light, PhD, a professor of social medicine and comparative health [...]

King Pharmaceuticals((R)), Inc. (NYSE KG) announced that the U.S. Food and Drug Administration (FDA) has approved EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use, a longacting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, aroundtheclock opioid analgesic is needed for an extended period [...]

Palatin Technologies, Inc. (NYSE Amex PTN) announced the completion of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without blood pressure [...]

GeoVax Labs, Inc. (OTC Bulletin Board GOVX), an Atlantabased HIV/AIDS vaccine development company announced updates on its ongoing and planned human clinical trials.
“We have two main areas of focus for our HIV/AIDS vaccine preventative and therapeutic,” stated Robert McNally, Ph.D., Chief Executive Officer and President of GeoVax Labs, Inc. “The results of the early [...]

Sanofiaventis (EURONEXT SAN and NYSE SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease. Multaq(R) is the first drug approved in the [...]